Exploring the Anti-cancer Potential of Ganoderma Lucidum Polysaccharides (GLPs) and Their Versatile Role in Enhancing Drug Delivery Systems: a Multifaceted Approach to Combat Cancer

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2023 Dec 16

PMID 38104078

Authors

Xiaoli Gao

Mina Homayoonfal

Affiliations

Soon will be listed here.

Abstract

There has been a growing global interest in the potential health benefits of edible natural bioactive products in recent years. Ganoderma lucidum, a medicinal mushroom, has gained attention for its decadent array of therapeutic and pharmaceutical compounds. Notably, G. lucidum exhibits significant anti-cancer effects against various cancer types. Polysaccharides, a prominent component in G. lucidum, are pivotal in conferring its diverse biological and medicinal properties. The primary focus of this study was to investigate the anti-cancer activities of G. lucidum polysaccharides (GLPs), with particular attention to their potential to mitigate chemotherapy-associated toxicity and enhance targeted drug delivery. Our findings reveal that GLPs exhibit anti-cancer effects through diverse mechanisms, including cytotoxicity, antioxidative properties, apoptosis induction, reactive oxygen species (ROS) generation, and anti-proliferative effects. Furthermore, the potential of GLPs-based nanoparticles (NPs) as delivery vehicles for bioactive constituents was explored. These GLPs-based NPs are designed to target various cancer tissues, enhancing the biological activity of encapsulated compounds. As such, GLPs derived from G. lucidum represent a promising avenue for inhibiting cancer progression, minimizing chemotherapy-related side effects, and supporting their utilization in combination therapies as natural adjuncts.

Citing Articles

Herbal based nanoparticles as a possible and potential treatment of cancer: a review.

Yadav R, Chawra H, Dubey G, Alam M, Kumar V, Sharma P Explor Target Antitumor Ther. 2025; 6:1002285.

PMID: 40061135 PMC: 11885881. DOI: 10.37349/etat.2025.1002285.

Structure-function insights of natural Ganoderma polysaccharides: advances in biosynthesis and functional food applications.

Wu Z, Zhao X, Quan C, Liu X, Tao X, Li Y Nat Prod Bioprospect. 2025; 15(1):15.

PMID: 40035898 PMC: 11880470. DOI: 10.1007/s13659-025-00496-w.

Bioactivities and industrial standardization status of : A comprehensive review.

Wu P, Zhang C, Yin Y, Zhang X, Li Q, Yuan L Heliyon. 2024; 10(19):e36987.

PMID: 39435114 PMC: 11492437. DOI: 10.1016/j.heliyon.2024.e36987.

Chemical Content and Cytotoxic Activity on Various Cancer Cell Lines of Chaga () Growing on and .

Raal A, Kaldmae H, Kutt K, Jurimaa K, Silm M, Bleive U Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204121 PMC: 11357148. DOI: 10.3390/ph17081013.

Medicinal Mushrooms in Metastatic Breast Cancer: What Is Their Therapeutic Potential as Adjuvant in Clinical Settings?.

De Luca F, Roda E, Rossi P, Bottone M Curr Issues Mol Biol. 2024; 46(7):7577-7591.

PMID: 39057091 PMC: 11276109. DOI: 10.3390/cimb46070450.

References

Ahmad M . Ganoderma lucidum: Persuasive biologically active constituents and their health endorsement. Biomed Pharmacother. 2018; 107:507-519. DOI: 10.1016/j.biopha.2018.08.036. View

Ahmad M . Ganoderma lucidum: A rational pharmacological approach to surmount cancer. J Ethnopharmacol. 2020; 260:113047. DOI: 10.1016/j.jep.2020.113047. View

Ahmad R, Riaz M, Khan A, Aljamea A, Algheryafi M, Sewaket D . Ganoderma lucidum (Reishi) an edible mushroom; a comprehensive and critical review of its nutritional, cosmeceutical, mycochemical, pharmacological, clinical, and toxicological properties. Phytother Res. 2021; 35(11):6030-6062. DOI: 10.1002/ptr.7215. View

Baby S, Johnson A, Govindan B . Secondary metabolites from Ganoderma. Phytochemistry. 2015; 114:66-101. DOI: 10.1016/j.phytochem.2015.03.010. View

Bains A, Chawla P, Kaur S, Najda A, Fogarasi M, Fogarasi S . Bioactives from Mushroom: Health Attributes and Food Industry Applications. Materials (Basel). 2021; 14(24). PMC: 8706457. DOI: 10.3390/ma14247640. View

Barreto-Bergter E, Figueiredo R . Fungal glycans and the innate immune recognition. Front Cell Infect Microbiol. 2014; 4:145. PMC: 4196476. DOI: 10.3389/fcimb.2014.00145. View

Carrieri R, Manco R, Sapio D, Iannaccone M, Fulgione A, Papaianni M . Structural data and immunomodulatory properties of a water-soluble heteroglycan extracted from the mycelium of an Italian isolate of Ganoderma lucidum. Nat Prod Res. 2017; 31(18):2119-2125. DOI: 10.1080/14786419.2017.1278593. View

Chang R . Functional properties of edible mushrooms. Nutr Rev. 1996; 54(11 Pt 2):S91-3. DOI: 10.1111/j.1753-4887.1996.tb03825.x. View

Chen J, Seviour R . Medicinal importance of fungal beta-(1-->3), (1-->6)-glucans. Mycol Res. 2007; 111(Pt 6):635-52. DOI: 10.1016/j.mycres.2007.02.011. View

10.

Chen S, Guan X, Yong T, Gao X, Xiao C, Xie Y . Structural characterization and hepatoprotective activity of an acidic polysaccharide from . Food Chem X. 2022; 13:100204. PMC: 9039936. DOI: 10.1016/j.fochx.2022.100204. View

11.

Chen X, Hu Z, Yang X, Huang M, Gao Y, Tang W . Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer. Int Immunopharmacol. 2006; 6(3):499-508. DOI: 10.1016/j.intimp.2005.08.026. View

12.

Chen Y, Wu Y, Hu C . Monosaccharide composition influence and immunomodulatory effects of probiotic exopolysaccharides. Int J Biol Macromol. 2019; 133:575-582. DOI: 10.1016/j.ijbiomac.2019.04.109. View

13.

de Camargo M, Frazon T, Inacio K, Smiderle F, Amor N, Dionisio T . Ganoderma lucidum polysaccharides inhibit in vitro tumorigenesis, cancer stem cell properties and epithelial-mesenchymal transition in oral squamous cell carcinoma. J Ethnopharmacol. 2021; 286:114891. DOI: 10.1016/j.jep.2021.114891. View

14.

Fang L, Zhao Q, Guo C, Guo D, Li Z, Xu J . Removing the sporoderm from the sporoderm-broken spores of improves the anticancer and immune-regulatory activity of water-soluble polysaccharide. Front Nutr. 2022; 9:1006127. PMC: 9524850. DOI: 10.3389/fnut.2022.1006127. View

15.

Ferreira I, Heleno S, Reis F, Stojkovic D, Queiroz M, Vasconcelos M . Chemical features of Ganoderma polysaccharides with antioxidant, antitumor and antimicrobial activities. Phytochemistry. 2014; 114:38-55. DOI: 10.1016/j.phytochem.2014.10.011. View

16.

Fitzgerald K, Kagan J . Toll-like Receptors and the Control of Immunity. Cell. 2020; 180(6):1044-1066. PMC: 9358771. DOI: 10.1016/j.cell.2020.02.041. View

17.

Fu Y, Shi L, Ding K . Structure elucidation and anti-tumor activity in vivo of a polysaccharide from spores of Ganoderma lucidum (Fr.) Karst. Int J Biol Macromol. 2019; 141:693-699. DOI: 10.1016/j.ijbiomac.2019.09.046. View

18.

Gao Y, Zhou S, Jiang W, Huang M, Dai X . Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. 2003; 32(3):201-15. DOI: 10.1081/imm-120022979. View

19.

Gazi U, Martinez-Pomares L . Influence of the mannose receptor in host immune responses. Immunobiology. 2009; 214(7):554-61. DOI: 10.1016/j.imbio.2008.11.004. View

20.

Golisch B, Lei Z, Tamura K, Brumer H . Configured for the Human Gut Microbiota: Molecular Mechanisms of Dietary β-Glucan Utilization. ACS Chem Biol. 2021; 16(11):2087-2102. DOI: 10.1021/acschembio.1c00563. View